Home Subjects Approval

Approval

Alembic Pharma gets USFDA nod for Darifenacin Extended Tablets

Mumbai, December 14, 2017: Pharma Major, Alembic Pharmaceuticals said that it company received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darifenacin extended release tablets, 7. 5mg and 15mg. Darifenacin extended release...

Biocon, Mylan’s Biosimilar Trastuzumab gets ANVISA’s approval

Mumbai, Janaury 04, 2018: Biotechnology mAJOR, Biocon and Mylan have received approval for Biosimilar Trastuzumab from ANVISA, the Brazilian regulatory agency, through their partner Libbs Farmaceutica (Libbs), a leading Brazilian pharmaceutical company. Co-developed by Biocon and Mylan, this is the first...

Lupin receives FDA approval for generic Tamiflu Capsules  

Mumbai, January 11, 2018: Pharma Major Lupin announced that it has received final approval for its Oseltamivir Phosphate Capsules USP,30 mg (base), 45 mg (base), and 75 mg (base) from the United States. UNI

TUV Rheinland extends A2LA Accreditation and FCC Approvals in Asia-Pacific’s most important markets

Addition of labs in Guangzhou and Shanghai in China, along with Bangalore in India will help customers meet the wireless, EMI and EMC testing and certification requirements for products aimed at the North American market Bengaluru, January 14, 2018: TUV Rheinland...

Jubilant Life receives ANDA approval for Amantadine Hydrochloride Tablets

Mumbai, February 10, 2018: Pharma Major,Jubilant Pharma said that its wholly owned subsidiary Jubilant Life Sciences' material has received Abbreviated New Drug Application (ANDA) final endorsement for Amantadine Hydrochloride Tablets, 100 mg, the generic version of Symmetrel of Endo,...

JB Chemicals receives USFDA nod for Atenolol tablets

Mumbai, December 14, 2017:Pharma firm, JB Chemicals & Pharmaceuticals has received USFDA approval for its Supplementary Abbreviated New Drug Application (sANDA) for Atenolol Tablets USP 25 mg. 50 mg.and 100 mg. (anti-hypertensive) manufactured using company's own bulk drug (API). The company had initiated this change as...

Alembic Pharma receives USFDA approval for Acyclovir ointment

Mumbai, April 16, 2018: Pharma Major, Alembic Pharma said that it has received USFDA approval for its Abbreviated New Drug Application (ANDA) Acyclovir ointment USP, 5 per cent. The approved ANDA is therapeutically equivalent to the reference listed drug product...

Sun Pharmaceuticals gets three perceptions on Halol plant from US FDA

Mumbai, February 27, 2018: Sun Pharmaceuticals Ltd said the US FDA issued a Shape 483 with three perceptions on its Halol office in Gujarat.Form 483 is issued when tranquilize assessors discover deviations from great assembling hones and the perceptions...

Cabinet approves MoU between India and Iran on cooperation in the field of...

New Delhi, March 16, 2018: The Union Cabinet chaired by Prime Minister Shri Narendra Modi has given its ex-post-facto approval for the Memorandum of Understanding (MoU) between India and Iran on cooperation in the field of Health and Medicine....

Lupin gets FDA endorsement for non specific Tamiflu for Oral Suspension

Mumbai, Febraury 22, 2018: Pharma real Lupin declared that it has gotten last endorsement for its Oseltamivir Phosphate for Oral Suspension from the Assembled States Sustenance and Medication Organization (FDA).